Acute generalized exanthematous pustulosis precipitated by hydroxychloroquine [6]

Journal of the American Academy of Dermatology

Volumn 50, Issue 4, 2004, Pages 650-651

  Evans, Colby C ^a   Bergstresser, Paul R ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; HYDROXYCHLOROQUINE;

ADULT; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG ERUPTION; FEMALE; FEVER; HUMAN; LETTER; PRIORITY JOURNAL; PUSTULOSIS; SKIN EXAMINATION; TOXIC EPIDERMAL NECROLYSIS;

EID: 1642338510     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(03)02733-6     Document Type: Article

References (5)

1. Roujeau JC, Bioulac-Sage P, Bourseau C, Guillaume JC, Bernard P, Lok C, et al. Acute generalized exanthematous pustulosis: analysis of 63 cases. Arch Dermatol 1991;127:1333-8.
2. Assier-Bonnet H, Saada V, Bernier M, Clerici T, Saiag P. Acute generalized exanthematous pustulosis induced by hydroxychloroquine. Dermatology 1996;193:70-1.
3. Janier M, Froidevaux D, Lons-Danic D, Daniel F. Acute generalized exanthematous pustulosis due to the combination of chloroquine and proguanil. Dermatology 1998;196:271.
4. Available from: URL: www.fda.gov/medwatch/safety/2000/oct00.htm.
5. Luzar MJ. Hydroxychloroquine in psoriatic arthropathy: exacerbations of psoriatic skin lesions. J Rheumatol 1982;9:462-4.